Back to School: How biopharma can reboot drug development. Access exclusive analysis here

NAS suggests restructuring NIH

NIH should be reorganized to better focus the federal government's investment in biomedical research on emerging needs and to develop a

Read the full 214 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE